Logo

American Heart Association

  21
  0


Final ID: MP1794

Adverse Clinical Events Due to the Safety Mode in Implantable Defibrillators

Abstract Body (Do not enter title and authors here): Introduction/Background: The Safety Mode (SM) in Boston Scientific pacemakers provides back-up pacing if a critical device malfunction or unexpected internal error occurs. However, SM's high sensitivity (0.25mV) and unipolar configuration have been associated with deaths and serious injuries due to oversensing and pacing inhibition in pacemaker-dependent patients. SM is also present in Boston Scientific 's implantable cardioverter-defibrillators (ICD) and cardiac resynchronization defibrillators (CRT-D) but it is unknown if any adverse effects SM has been caused in patients with these devices. When a Boston Scientific ICD or CRT-D enters SM, it paces VVI or BiV, fixed rate 72.5 min-1, unipolar autogain sensitivity 0.25mV, single zone ventricular fibrillation (VF) with a rate threshold of 165 min-1 and 5 maximum output shocks per episode. Moreover, tachycardia and defibrillation therapy may be disabled if additional faults occur while the device is in SM.
Research Question: Is SM in Boston Scientific ICDs and CRT-Ds associated with major adverse clinical events (MACE)?
Methods: The FDA’s Manufacturer and User Facility Device Experience (MAUDE) database was searched from January 2021-May 2025 for MACE involving SM in Boston Scientific ICDs and CRT-Ds.
Results: The search found 217 worldwide SM events that Boston Scientific classified as death (n=2; 1%), injury (n=178; 82%), or malfunction (n=37; 17%). Deaths were associated with a shorted ICD lead and a ventricular arrhythmia requiring external defibrillation. Thirty-three events (15%) involved SM-related inappropriate shocks (IAS) and 3 of these also had asystole due to pacing inhibition. One injury event was ventricular tachycardia (VT) that was not treated by the ICD due to SM. Of the 165 devices removed and analyzed, the causes of SM included memory inconsistencies (n=102; 62%), electronic component defects (n=17; 10%) and latent leakage paths in the battery (n=7; 4%).
Conclusions: SM in Boston Scientific ICDs and CRT-Ds is often caused by software errors and is associated with MACE including IAS, asystole, and failure to treat VT. Importantly, VT/VF therapy is not assured when a Boston Scientific ICD or CRT-D is in SM. These findings and the experience with pacemakers suggest the Boston Scientific Safety Mode should be redesigned.
  • Desouki, Mariam  ( MHIF , Minneapolis , Minnesota , United States )
  • Abdelsayed, Kerollos  ( Minneapolis Heart Institute , Minneapolis , Minnesota , United States )
  • Witt, Dawn  ( Minneapolis Heart Institute Foundat , Minneapolis , Minnesota , United States )
  • Sengupta, Jay  ( Allina Minneapolis Heart Institute , Eden Prairie , Minnesota , United States )
  • Hauser, Robert  ( MHIF , Minneapolis , Minnesota , United States )
  • Author Disclosures:
    Mariam Desouki: DO NOT have relevant financial relationships | Kerollos Abdelsayed: DO NOT have relevant financial relationships | Dawn Witt: No Answer | Jay Sengupta: No Answer | Robert Hauser: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Innovations and Safety Considerations in Cardiac Implantable Electronic Devices

Sunday, 11/09/2025 , 03:15PM - 04:30PM

Moderated Digital Poster Session

More abstracts on this topic:
Catheter Ablation for Ventricular Tachycardia in Ischemic Cardiomyopathy: A Meta-Analysis with Reconstructed Time-to-Event and Trial Sequential Analysis

Elbenawi Hossam, Kalaiger Abdul Mukhtadir, Ibrahim Ahmed, Eisa Mahmoud, Ibrahim Ramzi, Zaaya Morad, Tan Min Choon, Almaadawy Omar, Quelal Analuisa Karol, Ul Abideen Asad Zain, Lee Justin, Elsalmouny Youmna, Siontis Konstantinos, Del-carpio Munoz Freddy, Desimone Christopher, Deshmukh Abhishek, Mohamed Kareem, Hashim Ahmed, Agarwal Siddharth, Wagdy Mohamed, Hamed Belal, Thakurathi Priyesh, Al-shammari Ali Saad

Clinical outcomes of cardiac synchronization with or without an implantable cardioverter defibrillator based on pooled data from 5 clinical trials: a patient-level meta-analysis

Shadrin Ilya, Kutyifa Valentina, Linde Cecilia, Young James, Tang Anthony, Al-khatib Sana, Inoue Lurdes, Schmidler Gillian, Mackenzie Michael, Friedman Daniel, Abraham William, Cleland John, Curtis Anne, Gold Michael

More abstracts from these authors:
Impact of Leadless Versus Transvenous Pacemakers on Tricuspid Valve Function: A Propensity-Matched Multicenter Time-to-Event Study (The LEADLESS-TR)

Abdelsayed Kerollos, Bahbah Ali, Desouki Mariam, Halvorson Emily, Witt Dawn, Hauser Robert, Hamid Nadira, Sengupta Jay

Device Dislodgement and Embolization associated with a New Leadless Pacemaker

Bahbah Ali, Sengupta Jay, Witt Dawn, Zishiri Edwin, Zakaib John, Abdelhadi Raed, Hauser Robert

You have to be authorized to contact abstract author. Please, Login
Not Available